Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
ASTH — Astrana Health, Inc.
NASDAQ
FULL STOCK PAGE →

Q4 2025 Earnings Call Summary

MAR 2, 2026
REVENUE
$950.5M -0.6%
NET MARGIN
0.6% +0.6 PTS
EPS
$0.12 +1478.9%
FREE CASH FLOW
-$6.0M -180.4%

No summary has been written for this call yet.